Articles, App Notes, Case Studies, & White Papers

31. Fit-For-Purpose Lipids Can Accelerate, Scale, And Improve RNA-LNP Drugs 6/22/2023

    Emerging biotech companies are investing in novel delivery capabilities to address different modalities' needs and extra-hepatic delivery. Explore steps to accelerate commercial nanomedicine delivery.

32. Navigating The Regulatory Landscape For mRNA-Based Therapeutics Post-COVID 11/21/2024

    While organizations adapt to evolving safety and efficacy standards for mRNA, collaboration remains essential for navigating challenges like differing regional requirements, higher dosing needs, and analytical complexities.

33. Buffer Management Solutions For Large-Scale Biomanufacturing 2/1/2018

    How outsourcing and technologies such as in-line conditioning and in-line dilution can help prevent resource constraints, save time, and reduce manufacturing footprint and cost in buffer preparation.

34. Simultaneous Extraction Of Mycoplasma, MMV, And Vesivirus Nucleic Acids From A Single Sample 6/7/2024

    Achieve early detection of cell culture contamination with a nucleic acid extraction system to provide an integrated system for rapid and sensitive detection of mycoplasma, MMV, and vesivirus.

35. Pulse Check: How To Assess Your In-House Biomanufacturing Capabilities 6/18/2018

    By checking the pulse of your organization, you can identify gaps and develop a plan for how to address them, so you can make the right decisions at the right time.

36. Data Processing For Mass Confirmation, Impurities Analysis Of Oligos 5/5/2022

    Explore an automated, compliance-ready LC-MS workflow for intact mass confirmation and purity analysis of synthetic oligonucleotides including siRNA and large single guide RNA oligonucleotides.

37. Selecting A CMO Partner For Sterile Injectable Manufacturing 11/10/2021

    Performing the transfer of a product or technology from a small-scale development process to full-scale commercial manufacturing can be difficult, but vetting for the right CMO partner can pose its own challenges.

38. Designing A Global Drug Development Program To Secure FDA Approval 2/7/2023

    Global clinical trials in the Asia-Pacific region are becoming an attractive solution for young biotech companies looking to utilize their capital efficiently and secure high-quality clinical data quickly.

39. A Global Overview Of Liver Cancer Clinical Studies 7/3/2024

    This FAQ examines advancements in liver cancer treatment, emphasizing innovative drugs, current clinical trials, and their potential effects on patient outcomes.

40. Genetic Engineering Medium Aiding The Transfection Of MSCs With siRNA 8/10/2023

    A newly developed genetic engineering medium is fueling the development of cell- and extracellular vesicle-based therapies.